FDA's Marks Sees 'Two Or Three Year Window' To Transform Gene Therapy Environment

Agency has to ‘think creatively’ to make gene therapies commercially viable, CBER director says, suggesting greater use of accelerated approval endpoints and advancing manufacturing technologies. Center is focused on recruiting mid-level career people with manufacturing experience.